Email Updates

You are here

AVAC's Blog: P-Values

  • Each year on May 18th, HIV Vaccine Awareness Day (HVAD), we recognize and thank the thousands of volunteers, community members, health professionals, advocates, policy makers and scientists who are working together to find a safe and effective AIDS vaccine. HVAD is a reminder that vaccine research is rarely linear, often unpredictable and always an essential component of a comprehensive response to the epidemic. It is also often a reminder that awareness of the next steps for vaccine development is limited, and HVAD is an annual opportunity to raise awareness.

    May 19, 2014
  • AVAC’s HVAD Toolkit includes a new set of infographics on the current state of the field, a set of fact sheets and other tools to help explain vaccine science in simple language.

    May 18, 2014
  • The guidelines, the first national guidelines for PrEP use, provide instructions for health providers about providing daily TDF/FTC as PrEP for individuals at “substantial risk for HIV infection”; visit PrEP Watch to learn more about the guidelines, download materials and more.

    May 14, 2014
  • From AVAC’s Research & Reality webinar series, this recent webinar focused on essential questions about what recent trials do—and do not—tell us about whether women will want or use prevention tools including microbicide gels, rings and oral tenofovir-based PrEP.

    Download the recording and slides here.

    April 17, 2014
  • Over the past few years, the pace of scale-up of voluntary medical male circumcision for HIV prevention has finally begun to acclerate around Africa. Many different stakeholders have worked to make this happen—service providers, community educators, wives and mothers, and the millions of men who have stepped up to undergo this simple procedure, which reduces the risk of HIV infection by roughly 70 percent, for life.

    April 16, 2014
  • From February 11-13 more than 80 advocates from throughout sub-Saharan Africa gathered in Harare, Zimbabwe, for AVAC’s Advocacy Partners’ Forum, an annual event to take stock of recent developments in HIV prevention research and implementation and to develop a strategy for the coming year.

    April 1, 2014
  • The following piece is adapted from a presentation given at the AVAC Partners’ Forum by Mannasseh Phiri, a columnist for Zambia’s Sunday Post and long-time HIV prevention advocate.

    Several things really! First, at least one night every week I’m awake thinking which 1,000 words to write in my HIV/AIDS weekly newspaper column—before my deadline.

    April 1, 2014
    Mannasseh Phiri
  • It’s been five years since we announced the first class of talented advocates in the AVAC Advocacy Fellowship Program—and in February, AVAC was thrilled to welcome seven new Fellows. These individuals joined the outgoing 2013 Fellows in Harare, Zimbabwe, for a joint wrap-up and orientation Fellows Workshop.

    February 21, 2014
  • See the powerful speech on the continued and urgent need for an HIV vaccine from the AVAC Advocacy Fellow, and read the conference highlights.

    October 31, 2013
  • In July, AVAC and Internews in Kenya organized a journalists briefing on PrePex, a non-surgical device for voluntary medical male circumcision (VMMC) pre-qualified by the World Health Organization (WHO). (Click here for more on this process.) This was the first in a planned series of journalist “cafés” designed to spark conversation about VMMC and the role of non-surgical devices.

    October 30, 2013